Skip to content
Mushroom Retreats

Psilocybin law in Vermont

Illegal Checked 26 October 2026

Psilocybin is illegal in Vermont: it is defined as a regulated hallucinogenic drug under 18 V.S.A. 4201(10), and unlawful possession is punishable by up to one year in prison under 18 V.S.A. 4235.

Psilocybin is a controlled substance with no lawful route for retreats or personal use. Some of these states fund research or trials. A summary of published sources, not legal advice.

Source status: Prohibited. Psilocybin remains a Schedule I drug under US federal law.

Scheduling

Psilocybin is named in the definition of "hallucinogenic drugs" in Vermont's regulated drugs law, 18 V.S.A. 4201(10). Vermont classifies drugs by category (regulated drugs) rather than by numbered schedules in statute. [18 V.S.A. 4201, Definitions, Vermont General Assembly, read 26 October 2026]

What the law says

Penalties

  • Knowingly and unlawfully possessing a hallucinogenic drug other than LSD is punishable by up to one year in prison, a fine of up to $2,000, or both (18 V.S.A. 4235(b)(1)). Higher penalties apply at 10, 100 and 1,000 or more doses (4235(b)(2) to (4)). [18 V.S.A. 4235, Hallucinogenic drugs, Vermont General Assembly, read 26 October 2026]

Bills

  • H.452 2025-2026

    An act relating to decriminalization of psilocybin-containing mushrooms and the establishment of the Psilocybin Therapeutic Consultation Program

    Would have decriminalized psilocybin-containing mushrooms and created a Psilocybin Therapeutic Consultation Program.

    Status: Read first time and referred to House Committee on Human Services on 28 Feb 2025; no further action, died at the end of the 2025-2026 biennium, 28 February 2025

  • S.106 2025-2026

    An act relating to continuing the Psychedelic Therapy Advisory Working Group

    Would have continued the Psychedelic Therapy Advisory Working Group created by Act 126 of 2024.

    Status: Referred to Senate Committee on Health and Welfare on 11 Mar 2025; no further action, died at the end of the 2025-2026 biennium, 11 March 2025

  • H.859 2025-2026

    An act relating to psychedelic therapy and clinical drug development trials

    Would have addressed psychedelic therapy and clinical drug development trials.

    Status: Read first time and referred to House Committee on Health Care on 3 Feb 2026; no further action, died at the end of the 2025-2026 biennium, 3 February 2026

  • S.114 2023-2024

    An act relating to the establishment of the Psychedelic Therapy Advisory Working Group

    Created the Psychedelic Therapy Advisory Working Group (Act 126).

    Status: Signed by the Governor 29 May 2024 (Act 126), effective 1 July 2024, 29 May 2024

Dated changes

  • 3 February 2026: Would have addressed psychedelic therapy and clinical drug development trials. Status: Read first time and referred to House Committee on Health Care on 3 Feb 2026; no further action, died at the end of the 2025-2026 biennium. Source
  • 11 March 2025: Would have continued the Psychedelic Therapy Advisory Working Group created by Act 126 of 2024. Status: Referred to Senate Committee on Health and Welfare on 11 Mar 2025; no further action, died at the end of the 2025-2026 biennium. Source
  • 28 February 2025: Would have decriminalized psilocybin-containing mushrooms and created a Psilocybin Therapeutic Consultation Program. Status: Read first time and referred to House Committee on Human Services on 28 Feb 2025; no further action, died at the end of the 2025-2026 biennium. Source
  • 29 May 2024: Created the Psychedelic Therapy Advisory Working Group (Act 126). Status: Signed by the Governor 29 May 2024 (Act 126), effective 1 July 2024. Source

The full law map, with 51 US entries and every country we cover, or every dated change.